3 Nuclear Energy Stocks Down 40% or More From Their Highs -- Only 1 Is a Real Opportunity Right Now.

NuScale and Oklo remain pre-commercial, trading 86% and 79% below their record highs and valued at 24 times 2027 revenue and 770 times next year's sales, respectively; the article says neither is expected to break even soon. BWX Technologies is presented as a more diversified, profitable nuclear investment, with analysts forecasting 2025–2028 revenue and EPS CAGRs of 13% and 16%, and valuation of 3 times next year's sales and 28 times next year's earnings. Nuclear stocks have retreated amid the Iran war, inflation and rising interest rates, while the longer-term sector outlook is supported by decarbonization and power demand.

Analysis

The investable distinction is less reactor design than time-to-cash-flow and control of qualified nuclear supply. BWX Technologies, Inc. (BWXT) has defense-linked work and regulated-material capabilities that may retain value even if commercial SMR schedules slip. If reactor deployments accelerate, qualified component and fuel capacity could become a bottleneck; BWXT may benefit across competing designs, but do not assume it is a supplier to NuScale or Oklo without order evidence. This creates a potentially better risk profile than owning a single unproven reactor platform, not proof that BWXT captures the buildout.

Near term, higher rates can compress long-duration project valuations, leaving SMR and OKLO vulnerable to further dilution or multiple contraction before commercial revenue. Their sharp declines, however, do not by themselves establish cheapness: execution milestones and financing runway matter more than drawdown. Over 1–3 months, watch BWXT orders, backlog conversion and guidance, plus regulatory and project milestones at SMR/OKLO. Over 6–18 months, the thesis requires actual customer commitments, licensing progress and credible construction schedules; announcements alone are weaker evidence.

Contrarian risk: BWXT’s relative stability may already be reflected in its earnings multiple, while a credible SMR/OKLO milestone could reprice their substantial optionality quickly. The bullish BWXT case is falsified by slowing defense or commercial orders, weaker guidance, or failure to convert backlog into earnings. The speculative-reactor bear case weakens materially with funded projects and verifiable licensing/construction progress.

Key Decisions for Investors

• Prefer a staged BWXT long on weakness over treating SMR or OKLO drawdowns as automatic value opportunities. Reassess against order growth, backlog conversion and management guidance; the article’s growth estimates are forecasts, not guarantees.
• Avoid an unhedged short in SMR or OKLO: binary milestones and high volatility create squeeze risk. Keep both on a watchlist pending evidence of funded projects, licensing progress and financing runway.
• Consider a small, risk-capped relative-value position—long BWXT against a smaller notional short basket of SMR and OKLO—only if position sizing accounts for the much greater volatility and milestone-driven upside in the shorts. Exit or reduce if either company demonstrates a credible, funded path to deployment.
• Track interest rates and project economics alongside reactor announcements. A sustained easing in financing conditions plus customer-backed deployments would challenge the near-term caution; deteriorating BWXT orders or guidance would invalidate the preferred long.